Combo treatment yields MRD-negative remissions in CLLAugust 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Having prescription drug coverage is associated with improved myeloma outcomesAugust 16, 2018Practice ManagementLymphoma & Plasma Cell Disorders
Groups release guidelines for CAR T treatment in childrenAugust 10, 2018ImmunotherapyPediatricsLymphoma & Plasma Cell Disorders
Autotransplant is linked to higher AML, MDS riskAugust 10, 2018Mixed TopicsLymphoma & Plasma Cell Disorders
Insurance is a matter of life or death for lymphoma patientsAugust 6, 2018Practice ManagementLymphoma & Plasma Cell DisordersFollicular Lymphoma
Treatment simulation could help personalize myeloma therapyJuly 31, 2018Lymphoma & Plasma Cell Disorders
Isavuconazole resolved invasive fungal disease in patients on ibrutinibJuly 29, 2018Lymphoma & Plasma Cell Disorders
Late mortality risk after childhood BMT is substantial, persistentJuly 28, 2018Lymphoma & Plasma Cell Disorders
Rituximab reduces risk of follicular lymphoma transformationJuly 25, 2018Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Adding elotuzumab improves myeloma PFS over pom/dex aloneJuly 18, 2018Lymphoma & Plasma Cell Disorders
Promising phase 3 results for ixazomib in multiple myelomaJuly 13, 2018Lymphoma & Plasma Cell Disorders
